Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomedicines|May 25, 2017
Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer CellsYosi Gilad, Michael Firer, Gary Gellerman
Frontiers in Immunology|December 30, 2022
Steroid receptor coactivators - their role in immunityYosi Gilad, David M Lonard, Bert W O'Malley
Cancers|February 10, 2021
Drug Combination in Cancer Treatment-From Cocktails to Conjugated CombinationsYosi Gilad, Gary Gellerman, David M Lonard, et al.
Frontiers in Immunology|May 3, 2024
Steroid receptor coactivators in Treg and Th17 cell biology and functionYosi Gilad, Ortal Shimon, Sang Jun Han, et al.
Scientific Reports|March 6, 2020
Author Correction: Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combinationYosi Gilad, Yossi Eliaz, Yang Yu, et al.
Scientific Reports|October 24, 2019
Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combinationYosi Gilad, Yossi Eliaz, Yang Yu, et al.
Communications Biology|March 26, 2021
A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cellsYosi Gilad, Yossi Eliaz, Yang Yu, et al.
Molecular Immunology|June 5, 2025
CRISPR-Cas9 engineering of human T regulatory cells - Design and optimization of a manufacturing processOrtal Shimon, Adam M Dean, Shoshana Cohen, et al.
Pageof 1